Endogenous reactive intermediates as modulators of cell signaling and cell death

Chemical Research in Toxicology

Volumn 19, Issue 2, 2006, Pages 173-194

  West, James D ^a,b   Marnett, Lawrence J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; ACTIVATING TRANSCRIPTION FACTOR 6; ALDEHYDE; CASPASE; CASPASE 12; CASPASE 2; CASPASE 4; CELL PROTEIN; CULLIN; DNA BASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLYUNSATURATED FATTY ACID; PROTEIN BCL XL; PROTEIN MDM2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

CELL CYCLE; CELL DEATH; CELL MEMBRANE PERMEABILITY; CYTOSKELETON; CYTOTOXICITY; DETOXIFICATION; DNA DAMAGE; DNA METABOLISM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; ENZYME RELEASE; ENZYME SUBSTRATE; GENE EXPRESSION REGULATION; HUMAN; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; LIPID MEMBRANE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MUTAGENICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; CELL DEATH; HEAT-SHOCK RESPONSE; HUMANS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 33644514643     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050321u     Document Type: Review

References (319)

1. Leist, M., and Jaattela, M. (2001) Four deaths and a funeral: From caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589-598.
2. Nathan, C. (2003) Specificity of a third kind: Reactive oxygen and nitrogen intermediates in cell signaling. J. Clin. Invest, 111, 769-778.
3. Andersen, J. K. (2004) Oxidative stress in neurodegeneration: Cause or consequence? Nat. Med. 10 (Suppl.), S18-S25.
4. Wright, A. F., Jacobson, S. G., Cideciyan, A. V., Roman, A. J., Shu, X., Vlachantoni, D., McInnes, R. R., and Riemersma, R. A. (2004) Lifespan and mitochondrial control of neurodegeneration. Nat. Genet. 36, 1153-1158.
5. Beckman, K. B., and Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78, 547-581.
6. Finkel, T., and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of aging. Nature 408, 239-247.
7. Pryor, W. A. (1986) Oxy-radicals and related species: Their formation, lifetimes, and reactions. Annu. Rev. Physiol. 48, 657-667.
8. Ischiropoulos, H., Zhu, L., and Beckman, J. S. (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298, 446-451.
9. Koppenol, W. H., Moreno, J. J., Pryor, W. A., Ischiropoulos, H., and Beckman, J. S. (1992) Peroxynitrite: A cloaked oxidant from superoxide and nitric oxide. Chem. Res. Toxicol. 5, 834-842.
10. Fridovich, I. (1997) Superoxide anion radical (O2 radical anion), superoxide dismutases, and related matters. J. Biol. Chem. 272, 18515-18517.
11. Hazen, S. L., Hsu, F. F., Mueller, D. M., Crowley, J. R., and Heinecke, J. W. (1996) Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98, 1283-1289.
12. Toyokuni, S. (1996) Iron-induced carcinogenesis: The role of redox regulation. Free Radical Biol. Med. 20, 553-566.
13. Marnett, L. J., Riggins, J. N., and West, J. D. (2003) Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest. 111, 583-593.
14. Sun, Y. (1990) Free radicals, antioxidant enzymes, and carcinogenesis. Free Radical Biol. Med. 8, 583-599.
15. Wang, D., Kreutzer, D. A., and Essigmann, J. M. (1998) Mutagenicity and repair of oxidative DNA damage: Insights from studies using defined lesions. Mutat. Res. 400, 99-115.
16. Marnett, L. J. (2000) Oxyradicals and DNA damage. Carcinogenesis 21, 361-370.
17. Gros, L., Saparbaev, M. K., and Laval, J. (2002) Enzymology of the repair of free radicals-induced DNA damage. Oncogene 21, 8905-8925.
18. Cadet, J., Douki, T., and Ravanat, J. L. (1997) Artifacts associated with the measurement of oxidized DNA bases. Environ. Health Perspect. 105, 1034-1039.
19. Stadtman, E. R. (2001) Protein oxidation in aging and age-related diseases. Ann. N.Y. Acad. Sci. 928, 22-38.
20. Dean, R. T., Fu, S., Stocker, R., and Davies, M. J. (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324, 1-18.
21. Heinecke, J. W. (1998) Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low-density lipoprotein hypothesis. Atherosclerosis 141, 1-15.
22. Levine, R. L., and Stadtman, E. R. (2001) Oxidative modification of proteins during aging. Exp. Gerontol. 36, 1495-1502.
23. Benedetti, A., Comporti, M., and Esterbauer, H. (1980) Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim. Biophys. Acta 620, 281-296.
24. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of Superoxide and nitric oxide. Arch. Biochem. Biophys. 288, 481-487.
25. Porter, N. A., Caldwell, S. E., and Mills, K. A. (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30, 277-290.
26. Dix, T. A., and Aikens, J. (1993) Mechanisms and biological relevance of lipid peroxidation initiation. Chem. Res. Toxicol. 6, 2-18.
27. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
28. Lee, S. H., Oe, T., and Blair, I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292, 2083-2086.
29. Pryor, W. A., Stanley, J. P., and Blair, E. (1976) Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 11, 370-379.
30. Schneider, C., Tallman, K. A., Porter, N. A., and Brash, A. R. (2001) Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 276, 20831-20838.
31. Lee, S. H., Silva Elipe, M. V., Arora, J. S., and Blair, I. A. (2005) Dioxododecenoic acid: A lipid hydroperoxide-derived bifunctional electrophile responsible for etheno DNA adduct formation. Chem. Res. Toxicol. 18, 566-578.
32. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T., Noguchi, N., and Niki, E. (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low-density lipoproteins. J. Biol. Chem. 273, 16058-16066.
33. Uchida, K., Kanematsu, M., Sakai, K., Matsuda, T., Hattori, N., Mizuno, Y., Suzuki, D., Miyata, T., Noguchi, N., Niki, E., and Osawa, T. (1998) Protein-bound acrolein: Potential markers for oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 95, 4882-4887.
34. Ichihashi, K., Osawa, T., Toyokuni, S., and Uchida, K. (2001) Endogenous formation of protein adducts with carcinogenic aldehydes: Implications for oxidative stress. J. Biol. Chem. 276, 23903-23913.
35. Sowell, J., Frei, B., and Stevens, J. F. (2004) Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma. Proc. Natl. Acad. Sci. U.S.A. 101, 17964-17969.
36. Anderson, M. M., Hazen, S. L., Hsu, F. F., and Heinecke, J. W. (1997) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive α-hydroxy and α, β-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99, 424-432.
37. Uchida, K. (2003) 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog. Lipid Res. 42, 318-343.
38. Sayre, L. M., Smith, M. A., and Perry, G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8, 721-738.
39. Lee, S. H., and Blair, I. A. (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698-702.
40. Mao, H., Schnetz-Boutaud, N. C., Weisenseel, J. P., Marnett, L. J., and Stone, M. P. (1999) Duplex DNA catalyzes the chemical rearrangement of a malondialdehyde deoxyguanosine adduct. Proc. Natl. Acad. Sci. U.S.A. 96, 6615-6620.
41. de los Santos, C., Zaliznyak, T., and Johnson, F. (2001) NMR characterization of a DNA duplex containing the major acrolein-derived deoxyguanosine adduct γ-OH-1,-N2-propano-2′-deoxyguanosine. J. Biol. Chem. 276, 9077-9082.
42. Schnetz-Boutaud, N., Daniels, J. S., Hashim, M. F., Scholl, P., Burrus, T., and Marnett, L. J. (2000) Pyrimido[1,2-α]purin-10(3H)-one: A reactive electrophile in the genome. Chem. Res. Toxicol. 13, 967-970.
43. Kozekov, I. D., Nechev, L. V., Sanchez, A., Harris, C. M., Lloyd, R. S., and Harris, T. M. (2001) Interchain cross-linking of DNA mediated by the principal adduct of acrolein. Chem. Res. Toxicol. 14, 1482-1485.
44. Kurtz, A. J., and Lloyd, R. S. (2003) 1,N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage. J. Biol. Chem. 278, 5970-5976.
45. Sanchez, A. M., Minko, I. G., Kurtz, A. J., Kanuri, M., Moriya, M., and Lloyd, R. S. (2003) Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived α-HOPdG and γ-HOPdG regioisomeric deoxyguanosine adducts. Chem. Res. Toxicol. 16, 1019-1028.
46. VanderVeen, L. A., Hashim, M. F., Shyr, Y., and Marnett, L. J. (2003) Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde. Proc. Natl. Acad. Sci. U.S.A. 100, 14247-14252.
47. Fernandes, P. H., Wang, H., Rizzo, C. J., and Lloyd, R. S. (2003) Site-specific mutagenicity of stereochemically defined 1,N2-deoxyguanosine adducts of trans-4-hydroxynonenal in mammalian cells. Environ. Mol. Mutagen. 42, 68-74.
48. Nadkarni, D. V., and Sayre, L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
49. Amarnath, V., Valentine, W. M., Montine, T. J., Patterson, W. H., Amarnath, K., Bassett, C. N., and Graham, D. G. (1998) Reactions of 4-hydroxy-2(E)-nonenal and related aldehydes with proteins studied by carbon-13 nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 11, 317-328.
50. Doorn, J. A., and Petersen, D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445-1450.
51. Zhang, W. H., Liu, J., Xu, G., Yuan, Q., and Sayre, L. M. (2003) Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 16, 512-523.
52. Sayre, L. M., Arora, P. K., Iyer, R. S., and Salomon, R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
53. Tsai, L., Szweda, P. A., Vinogradova, O., and Szweda, L. I. (1998) Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc. Natl. Acad. Sci. U.S.A. 95, 7975-7980.
54. Itakura, K., Osawa, T., and Uchida, K. (1998) Structure of a fluorescent compound formed from 4-hydroxy-2-nonenal and N-α-hippuryllysine: A model for fluorophores derived from protein modifications by lipid peroxidation. J. Org. Chem. 63, 185-187.
55. Zhang, Q., Powers, E. T., Nieva, J., Huff, M. E., Dendle, M. A., Bieschke, J., Glabe, C. G., Eschenmoser, A., Wentworth, P., Jr., Lerner, R. A., and Kelly, J. W. (2004) Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 4752-4757.
56. Uchida, K., Shiraishi, M., Naito, Y., Torii, Y., Nakamura, Y., and Osawa, T. (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274, 2234-2242.
57. Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B. (1994) Detoxication of base propenals and other α, β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. U.S.A. 91, 1480-1484.
58. Hartley, D. P., Ruth, J. A., and Petersen, D. R. (1995) The hepatocellular metabolism of 4-hydroxynonenaI by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch. Biochem. Biophys. 316, 197-205.
59. Haynes, R. L., Szweda, L., Pickin, K., Welker, M. E., and Townsend, A. J. (2000) Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in raw 264.7 cells. Mol. Pharmacol. 8, 788-794.
60. Burczynski, M. E., Sridhar, G. R., Palackal, N. T., and Penning, T. M. (2001) The reactive oxygen species-and Michael acceptor-inducible human aldo-keto reductase AKRICI reduces the alpha,-beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 276, 2890-2897.
61. Dick, R. A., Kwak, M. K., Sutter, T. R., and Kensler, T. W. (2001) Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12- hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 276, 40803-40810.
62. Doom, J. A., Srivastava, S. K., and Petersen, D. R. (2003) Aldose reductase catalyzes reduction of the lipid peroxidation product 4-oxonon-2-enal. Chem. Res. Toxicol. 16, 1418-1423.
63. Doorn, J. A., Maser, E., Blum, A., Claffey, D. J., and Petersen, D. R. (2004) Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal. Biochemistry: 43, 13106-13114.
64. Chung, F. L., Nath, R. G., Ocando, J., Nishikawa, A., and Zhang, L. (2000) Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: Detection and potential sources. Cancer Res. 60, 1507-1511.
65. Hashimoto, M., Sibata, T., Wasada, H., Toyokuni, S., and Uchida, K. (2003) Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J. Biol. Chem. 278, 5044-5051.
66. Sayre, L. M., Zelasko, D. A., Harris, P. L., Perry, G., Salomon, R. G., and Smith, M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092-2097.
67. Montine, K. S., Olson, S. J., Amarnath, V., Whetsell, W. O., Jr., Graham, D. G., and Montine, T. J. (1997) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Palhol. 150, 437-443.
68. Salomon, R. G., Kaur, K., Podrez, E., Hoff, H. F., Krushinsky, A. V., and Sayre, L. M. (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem. Res. Toxicol. 13, 557-564.
69. Kumar, D., and Jugdutt, B. I. (2003) Apoptosis and oxidants in the heart. J. Lab. Clin. Med. 142, 288-297.
70. Warner, D. S., Sheng, H., and Batinic-Haberle, I. (2004) Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207, 3221-3231.
71. Proskuryakov, S. Y., Konoplyannikov, A. G., and Gabai, V. L. (2003) Necrosis: A specific form of programmed cell death? Exp. Cell Res. 283, 1-16.
72. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
73. Wyllie, A. H., Kerr, J. F., and Currie, A. R. (1980) Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
74. Nelson, D. A., and White, E. (2004) Exploiting different ways to die. Genes Dev. 18, 1223-1226.
75. Ha, H. C., and Snyder, S. H. (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 96, 13978-13982.
76. Eliasson, M. J., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J., Pieper, A., Wang, Z. Q., Dawson, T. M., Snyder, S. H., and Dawson, V. L. (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3, 1089-1095.
77. Virag, L., and Szabo, C. (2002) The therapeutic potential of poly-(ADP-Ribose) polymerase inhibitors. Pharmacol. Rev. 54, 375-429.
78. Lo, E. H., Bosque-Hamilton, P., and Meng, W. (1998) Inhibition of poly(ADP-ribose) polymerase: Reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke 29, 830-836.
79. Burkart, V., Wang, Z. Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E. F., and Kolb, H. (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic β-cell destruction and diabetes development induced by streptozocin. Nat. Med. 5, 314-319.
80. Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K., Watanabe, T., Sugimoto, T., Nakagama, H., Ochiya, T., and Sugimura, T. (1999) Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96, 2301-2304.
81. Pieper, A. A., Brat, D. J., Krug, D. K., Watkins, C. C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z. Q., and Snyder, S. H. (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96, 3059-3064.
82. Yu, S. W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., and Dawson, V. L. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259-263.
83. Zong, W. X., Ditsworth, D., Bauer, D. E., Wang, Z. Q., and Thompson, C. B. (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272-1282.
84. Lockshin, R. A., and Williams, C. M. (1965) Programmed cell death. IV. The influence of drugs on the breakdown of the intersegmental muscles of silkmoths. J. Insect Physiol. 11, 803-809.
85. Sulston, J. E., and Horvitz, H. R. (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis eleganx. Dev. Biol. 56, 110-156.
86. Vaux, D. L. (2002) Apoptosis timeline. Cell Death Differ. 9, 349-354.
87. Degterev, A., Boyce, M., and Yuan, J. (2003) A decade of caspases. Oncogene 22, 8543-8567.
88. Earnshaw, W. C., Martins, L. M., and Kaufmann, S. H. (1999) Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68, 383-424.
89. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., and Aunins, J. (1992) A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature 356, 768-774.
90. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., and Cannizzaro, L. A. (1992) Molecular cloning of the interleukin-1 β converting enzyme. Science 256, 97-100.
91. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A., and Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-1 β-converting enzyme, a mammalian homologue of the C. elegans cell death gene ced-3. Cell 75, 653-660.
92. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 β-converting enzyme. Cell 75, 641-652.
93. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., and Lazebnik, Y. A. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
94. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87, 171.
95. Strasser, A., O'Connor, L., and Dixit, V. M. (2000) Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245.
96. Thornberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia-Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, K. T., and Nicholson, D. W. (1997) A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272, 17907-17911.
97. Ferri, K. F., and Kroemer, G. (2001) Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3, E255-E263.
98. Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., and Korsmeyer, S. J. (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41, 899-906.
99. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440-1443.
100. Cleary, M. L., and Sklar, J. (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. U.S.A. 82, 7439-7443.
101. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
102. Hengartner, M. O., Ellis, R. E., and Horvitz, H. R. (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356, 494-499.
103. Chen-Levy, Z., Nourse, J., and Cleary, M. L. (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell Biol. 9, 701-710.
104. Newmeyer, D. D., Farschon, D. M., and Reed, J. C. (1994) Cell-free apoptosis in Xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79, 353-364.
105. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. (1997) The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
106. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P., and Wang, X. (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
107. Kharbanda, S., Pandey, P., Schofield, L., Israels, S., Roncinske, R., Yoshida, K., Bharti, A., Yuan, Z. M., Saxena, S., Weichselbaum, R., Nalin, C., and Kufe, D. (1997) Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 6939-6942.
108. Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., and Thompson, C. B. (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
109. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
110. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911.
111. Scorrano, L., and Korsmeyer, S. J. (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304, 437-444.
112. Mattson, M. P., and Kroemer, G. (2003) Mitochondria in cell death: Novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 9, 196-205.
113. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
114. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
115. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86, 147-157.
116. Acehan, D., Jiang, X., Morgan, D. G., Heuser, J. E., Wang, X., and Akey, C. W. (2002) Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432.
117. Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., and Salvesen, G. S. (2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. U.S.A. 98, 14250-14255.
118. Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S. M., Alnemri, E. S., Fairman, R., and Shi, Y. (2003) Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11, 519-527.
119. Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R., and Salvesen, G. S. (2003) A unified model for apical caspase activation. Mol. Cell 11, 529-541.
120. Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H. G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., Green, D. R., and Martin, S. J. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292.
121. Newmeyer, D. D., and Ferguson-Miller, S. (2003) Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 112, 481-490.
122. Salvesen, G. S., and Duckett, C. S. (2002) IAP proteins: Blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3, 401-410.
123. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42.
124. Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., and Vaux, D. L. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53.
125. Liu, Z., Sun, C., Olejniczak, E. T., Meadows, R. P., Betz, S. F., Oost, T., Herrmann, J., Wu, J. C., and Fesik, S. W. (2000) Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408, 1004-1008.
126. Wu, G., Chai, J., Suber, T. L., Wu, J. W., Du, C., Wang, X., and Shi, Y. (2000) Structural basis of IAP recognition by Smac/DIABLO. Nature 408, 1008-1012.
127. Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., and Takahashi, R. (2001) A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 8, 613-621.
128. Lassus, P., Opitz-Araya, X., and Lazebnik, Y. (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297, 1352-1354.
129. Robertson, J. D., Enoksson, M., Suomela, M., Zhivotovsky, B., and Orrenius, S. (2002) Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 277, 29803-29809.
130. Read, S. H., Baliga, B. C., Ekert, P. G., Vaux, D. L., and Kumar, S. (2002) A novel Apaf-1-independent putative caspase-2 activation complex. J. Cell Biol. 159, 739-745.
131. Tinel, A., and Tschopp, J. (2004) The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304, 843-846.
132. Lin, Y., Ma, W., and Benchimol, S. (2000) Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat. Genet. 26, 122-127.
133. Telliez, J. B., Bean, K. M., and Lin, L. L. (2000) LRDD, a novel leucine rich repeat and death domain containing protein. Biochim. Biophys. Acta 1478, 280-288.
134. Duan, H., and Dixit, V. M. (1997) RAIDD is a new "death" adaptor molecule. Nature 385, 86-89.
135. Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T., and Alnemri, E. S. (2002) Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 277, 13430-13437.
136. Hitomi, J., Katayama, T., Eguchi, Y., Kudo, T., Taniguchi, M., Koyama, Y., Manabe, T., Yamagishi, S., Bando, Y., Imaizumi, K., Tsujimoto, Y., and Tohyama, M. (2004) Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and A β-induced cell death. J. Cell Biol. 165, 347-356.
137. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A., and Yuan, J. (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403, 98-103.
138. Saleh, M., Vaillancourt, J. P., Graham, R. K., Huyck, M., Srinivasula, S. M., Alnemri, E. S., Steinberg, M. H., Nolan, V., Baldwin, C. T., Hotchkiss, R. S., Buchman, T. G., Zehnbauer, B. A., Hayden, M. R., Farrer, L. A., Roy, S., and Nicholson, D. W. (2004) Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 429, 75-79.
139. Obeng, E. A., and Boise, L. H. (2005) Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 280, 29578-29587.
140. Nagata, S., and Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
141. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375, 81-83.
142. Enari, M., Hug, H., and Nagata, S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
143. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., and Peter, M. E. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
144. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
145. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., and Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
146. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1996) Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U.S.A. 93, 14486-14491.
147. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
148. Stennicke, H. R., Jurgensmeier, J. M., Shin, H., Deveraux, Q., Wolf, B. B., Yang, X., Zhou, Q., Ellerby, H. M., Ellerby, L. M., Bredesen, D., Green, D. R., Reed, J. C., Froelich, C. J., and Salvesen, G. S. (1998) Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem. 273, 27084-27090.
149. Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., and Korsmeyer, S. J. (1996) BID: A novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869.
150. Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998) Cleavage of BID by caspase 8 mediates the mitochondria! damage in the Fas pathway of apoptosis. Cell 94, 491-501.
151. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-490.
152. Cryns, V. L., Bergeron, L., Zhu, H., Li, H., and Yuan, J. (1996) Specific cleavage of α-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1β-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271, 31277-31282.
153. Janicke, R. U., Ng, P., Sprengart, M. L., and Porter, A. G. (1998) Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273, 15540-15545.
154. Martin, S. J., O'Brien, G. A., Nishioka, W. K., McGahon, A. J., Mahboubi, A., Saido, T. C., and Green, D. R. (1995) Proteolysis of fodrin (nonerythroid spectrin) during apoptosis. J. Biol. Chem. 270, 6425-6428.
155. Brancolini, C., Benedetti, M., and Schneider, C. (1995) Microfilament reorganization during apoptosis: The role of Gas2, a possible substrate for ICE-like proteases. EMBO J. 14, 5179-5190.
156. Sgorbissa, A., Benetti, R., Marzinotto, S., Schneider, C., and Brancolini, C. (1999) Caspase-3 and caspase-7 but not caspase-6 cleave Gas2 in vitro: Implications for microfilament reorganization during apoptosis. J. Cell Sci. 112 (Part 23), 4475-4482.
157. Brancolini, C., Lazarevic, D., Rodriguez, J., and Schneider, C. (1997) Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of α-catenin. J. Cell Biol. 139, 759-771.
158. Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A., and Olson, M. F. (2001) Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3, 339-345.
159. Sebbagh, M., Renvoize, C., Hamelin, J., Riche, N., Bertoglio, J., and Breard, J. (2001) Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346-352.
160. Rudel, T., and Bokoch, G. M. (1997) Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 276, 1571-1574.
161. Walter, B. N., Huang, Z., Jakobi, R., Tuazon, P. T., Alnemri, E. S., Litwack, G., and Traugh, J. A. (1998) Cleavage and activation of p21-activated protein kinase γ-PAK by CPP32 (caspase 3). Effects of autophosphorylation on activity. J. Biol. Chem. 273, 28733-28739.
162. Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J., and Williams, L. T. (1997) Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 278, 294-298.
163. Lee, N., MacDonald, H., Reinhard, C., Halenbeck, R., Roulston, A., Shi, T., and Williams, L. T. (1997) Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 13642-13647.
164. Emoto, Y., Manome, Y., Meinhardt, G., Kisaki, H., Kharbanda, S., Robertson, M., Ghayur, T., Wong, W. W., Kamen, R., and Weichselbaum, R. (1995) Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J. 14, 6148-6156.
165. Ghayur, T., Hugunin, M., Talanian, R. V., Ratnofsky, S., Quinlan, C.,
166. Denning, M. F., Wang, Y., Nickoloff, B. J., and Wrone-Smith, T. (1998) Protein kinase C δ is activated by caspase-dependent proteolysis during ultraviolet radiation-induced apoptosis of human keratinocytes. J. Biol. Chem. 273, 29995-30002.
167. Datta, R., Kojima, H., Yoshida, K., and Kufe, D. (1997) Caspase-3-mediated cleavage of protein kinase C θ in induction of apoptosis. J. Biol. Chem. 272, 20317-20320.
168. Cryns, V. L., Byun, Y., Rana, A., Mellor, H., Lustig, K. D., Ghanem, L., Parker, P. J., Kirschner, M. W., and Yuan, J. (1997) Specific proteolysis of the kinase protein kinase C-related kinase 2 by caspase-3 during apoptosis. Identification by a novel, small pool expression cloning strategy. J. Biol. Chem. 272, 29449-29453.
169. Frasch, S. C., Henson, P. M., Kailey, J. M., Richter, D. A., Janes, M. S., Fadok, V. A., and Bratton, D. L. (2000) Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase C δ. J. Biol. Chem. 275, 23065-23073.
170. Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroemer, G. (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184, 1155-1160.
171. Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., Susin, S. A., Petit, P. X., Mignotte, B., and Kroemer, G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
172. Ricci, J. E., Gottlieb, R. A., and Green, D. R. (2003) Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 160, 65-75.
173. Ricci, J. E., Munoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G. A., Yadava, N., Scheffler, I. E., Ellisman, M. H., and Green, D. R. (2004) Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117, 773-786.
174. Takahashi, A., Alnemri, E. S., Lazebnik, Y. A., Fernandes-Alnemri, T., Litwack, G., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1996) Cleavage of lamin A by Mch2 α but not CPP32: Multiple interleukin 1 β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 8395-8400.
175. Orth, K., Chinnaiyan, A. M., Garg, M., Froelich, C. J., and Dixit, V. M. (1996) The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271, 16443-16446.
176. McConkey, D. J. (1996) Calcium-dependent, interleukin 1-converting enzyme inhibitor-insensitive degradation of lamin B1 and DNA fragmentation in isolated thymocyte nuclei. J. Biol. Chem. 271, 22398-22406.
177. Lazebnik, Y. A., Takahashi, A., Moir, R. D., Goldman, R. D., Poirier, G. G., Kaufmann, S. H., and Earnshaw, W. C. (1995) Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. U.S.A. 92, 9042-9046.
178. Rao, L., Perez, D., and White, E. (1996) Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell Biol. 135, 1441-1455.
179. Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175-184.
180. Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W. T., and Wang, X. (1998) The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 95, 8461-8466.
181. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
182. Sakahira, H., Enari, M., and Nagata, S. (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391, 96-99.
183. Halenbeck, R., MacDonald, H., Roulston, A., Chen, T. T., Conroy, L., and Williams, L. T. (1998) CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45. Curr. Biol. 8, 537-540.
184. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985.
185. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties such as ICE. Nature 371, 346-347.
186. Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., and Rosen, A. (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 183, 1957-1964.
187. Song, Q., Lees-Miller, S. P., Kumar, S., Zhang, Z., Chan, D. W., Smith, G. C., Jackson, S. P., Alnemri, E. S., Litwack, G., Khanna, K. K., and Lavin, M. F. (1996) DNA-dependent protein kinase catalytic subunit: A target for an ICE-like protease in apoptosis. EMBO J. 15, 3238-3246.
188. Han, Z., Malik, N., Carter, T., Reeves, W. H., Wyche, J. H., and Hendrickson, E. A. (1996) DNA-dependent protein kinase is a target for a CPP32-like apoptotic protease. J. Biol. Chem. 271, 25035-25040.
189. Smith, G. C., d'Adda di Fagagna, F., Lakin, N. D., and Jackson, S. P. (1999) Cleavage and inactivation of ATM during apoptosis. Mol. Cell. Biol. 19, 6076-6084.
190. Boulares, A. H., Zoltoski, A. J., Yakovlev, A., Xu, M., and Smulson, M. E. (2001) Roles of DNA fragmentation factor and poly(ADP-ribose) polymerase in an amplification phase of tumor necrosis factor-induced apoptosis. J. Biol. Chem. 276, 38185-38192.
191. West, J. D., Ji, C., and Marnett, L. J. (2005) Modulation of DNA fragmentation factor 40 nuclease activity by poly(ADP-ribose) polymerase-1. J. Biol. Chem. 280, 15141-15147.
192. Rogakou, E. P., Nieves-Neira, W., Boon, C., Pommier, Y., and Bonner, W. M. (2000) Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J. Biol. Chem. 275, 9390-9395.
193. Chuang, Y. Y., Chen, Y., Gadisetti, Chandramouli, V. R., Cook, J. A., Coffin, D., Tsai, M. H., DeGraff, W., Yan, H., Zhao, S., Russo, A., Liu, E. T., and Mitchell, J. B. (2002) Gene expression after treatment with hydrogen peroxide, menadione, or tert-butyl hydroperoxide in breast cancer cells. Cancer Res. 62, 6246-6254.
194. Kyng, K. J., May, A., Brosh, R. M., Jr., Cheng, W. H., Chen, C., Becker, K. G., and Bohr, V. A. (2003) The transcriptional response after oxidative stress is defective in Cockayne syndrome group B cells. Oncogene 22, 1135-1149.
195. Kemp, T. J., Causton, H. C., and Clerk, A. (2003) Changes in gene expression induced by H(2)O(2) in cardiac myocytes. Biochem. Biophys. Res. Commun. 307, 416-421.
196. Murray, J. I., Whitfield, M. L., Trinklein, N. D., Myers, R. M., Brown, P. O., and Botstein, D. (2004) Diverse and specific gene expression responses to stresses in cultured human cells. Mol. Biol. Cell 15, 2361-2374.
197. West, J. D., and Marnett, L. J. (2005) Alterations in gene expression induced by the lipid peroxidation product, 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18, 1642-1653.
198. Nguyen, T., Sherratt, P. J., and Pickett, C. B. (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43, 233-260.
199. Jaiswal, A. K. (2004) Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biol. Med. 36, 1199-1207.
200. Dinkova-Kostova, A. T., Holtzclaw, W. D., and Kensler, T. W. (2005) The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 18, 1779-1791.
201. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., and Yamamoto, M. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13, 76-86.
202. Kang, M. I., Kobayashi, A., Wakabayashi, N., Kim, S. G., and Yamamoto, M. (2004) Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc. Natl. Acad. Sci. U.S.A. 101, 2046-2051.
203. Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., and Diehl, J. A. (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell Biol. 24, 8477-8486.
204. Furukawa, M., and Xiong, Y. (2005) BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell Biol. 25, 162-171.
205. Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. (2004) Oxidative stress sensor Keapl functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell Biol. 24, 7130-7139.
206. Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J., and Hannink, M. (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell Biol. 24, 10941-10953.
207. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., and Talalay, P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908-11913.
208. Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M. I., Kobayashi, A., Yamamoto, M., Kensler, T. W., and Talalay, P. (2004) Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 101, 2040-2045.
209. Levonen, A. L., Landar, A., Ramachandran, A., Ceaser, E. K., Dickinson, D. A., Zanoni, G., Morrow, J. D., and Darley-Usmar, V. M. (2004) Cellular mechanisms of redox cell signaling: Role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J. 378, 373-382.
210. Eggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., and Mesecar, A. D. (2005) Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. U.S.A. 102, 10070-10075.
211. Zhang, D. D., Lo, S. C., Sun, Z., Habib, G. M., Lieberman, M. W., and Hannink, M. (2005) Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J. Biol. Chem. 280, 30091-30099.
212. Hong, F., Sekhar, K. R., Freeman, M. L., and Liebler, D. C. (2005) Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280, 31768-31775.
213. Katsuoka, F., Motohashi, H., Ishii, T., Aburatani, H., Engel, J. D., and Yamamoto, M. (2005) Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol. Cell Biol. 25, 8044-8051.
214. Bloom, D. A., and Jaiswal, A. K. (2003) Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278, 44675-44682.
215. Huang, H. C., Nguyen, T., and Pickett, C. B. (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277, 42769-42774.
216. Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., and Diehl, J. A. (2003) Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell Biol. 23, 7198-7209.
217. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., and Biswal, S. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62, 5196-5203.
218. Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W., and Johnson, J. A. (2003) Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278, 12029-12038.
219. Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., and Kensler, T. W. (2003) Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278, 8135-8145.
220. Moinova, H. R., and Mulcahy, R. T. (1999) Up-regulation of the human γ-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem. Biophys. Res. Commun. 261, 661-668.
221. Wild, A. C., Moinova, H. R., and Mulcahy, R. T. (1999) Regulation of γ-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274, 33627-33636.
222. McMahon, M., Itoh, K., Yamamoto, M., Chanas, S. A., Henderson, C. J., McLellan, L. I., Wolf, C. R., Cavin, C, and Hayes, J. D. (2001) The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 61, 3299-3307.
223. Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M., and Bannai, S. (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277, 44765-44771.
224. Chen, Z. H., Saito, Y., Yoshida, Y., Sekine, A., Noguchi, N., and Niki, E. (2005) 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J. Biol. Chem. 280, 41921-41927.
225. Morimoto, R. I. (1998) Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 12, 3788-3796.
226. Shi, Y., Mosser, D. D., and Morimoto, R. I. (1998) Molecular chaperones as HSF1-specific transcriptional repressers. Genes Dev. 12, 654-666.
227. Duina, A. A., Kalton, H. M., and Gaber, R. F. (1998) Requirement for Hsp90 and a CyP-40-type cyclophilin in negative regulation of the heat shock response. J. Biol. Chem. 273, 18974-18978.
228. Zou, J., Guo, Y., Guettouche, T., Smith, D. F., and Voellmy, R. (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94, 471-480.
229. Ahn, S. G., and Thiele, D. J. (2003) Redox regulation of mammalian heat shock factor 1 is essential for Hsp gene activation and protection from stress. Genes Dev. 17, 516-528.
230. Jolly, C., and Morimoto, R. I. (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 92, 1564-1572.
231. Saleh, A., Srinivasula, S. M., Balkir, L., Robbins, P. D., and Alnemri, E. S. (2000) Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat. Cell. Biol. 2, 476-483.
232. Beere, H. M., Wolf, B. B., Cain, K., Mosser, D. D., Mahboubi, A., Kuwana, T., Tailor, P., Morimoto, R. I., Cohen, G. M., and Green, D. R. (2000) Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat. Cell Biol. 2, 469-475.
233. Mosser, D. D., Caron, A. W., Bourget, L., Denis-Larose, C., and Massie, B. (1997) Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell Biol. 17, 5317-5327.
234. Mosser, D. D., Caron, A. W., Bourget, L., Meriin, A. B., Sherman, M. Y., Morimoto, R. I., and Massie, B. (2000) The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell Biol. 20, 7146-7159.
235. Ron, D. (2002) Translational control in the endoplasmic reticulum stress response. J. Clin. Invest. 110, 1383-1388.
236. Zhang, K., and Kaufman, R. J. (2004) Signaling the unfolded protein response from the endoplasmic reticulum. J. Biol. Chem. 279, 25935-25938.
237. Ye, J., Rawson, R. B., Komuro, R., Chen, X., Dave, U. P., Prywes, R., Brown, M. S., and Goldstein, J. L. (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol. Cell 6, 1355-1364.
238. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T., and Mori, K. (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107, 881-891.
239. Lee, A. H., Iwakoshi, N. N., and Glimcher, L. H. (2003) XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell Biol. 23, 7448-7459.
240. Shen, J., Chen, X., Hendershot, L., and Prywes, R. (2002) ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell 3, 99-111.
241. Shen, J., Snapp, E. L., Lippincott-Schwartz, J., and Prywes, R. (2005) Stable binding of ATF6 to BiP in the endoplasmic reticulum stress response. Mol. Cell Biol. 25, 921-932.
242. Bertolotti, A., Zhang, Y., Hendershot, L. M., Harding, H. P., and Ron, D. (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2, 326-332.
243. Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H., and Ron, D. (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 5, 897-904.
244. Jiang, H. Y., and Wek, R. C. (2005) Phosphorylation of the α-subunit of the eukaryotic initiation factor-2 (eIF2α) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280, 14189-14202.
245. Harding, H. P., Zhang, Y., and Ron, D. (1999) Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 397, 271-274.
246. Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., and Ron, D. (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 6, 1099-1108.
247. Siu, F., Bain, P. J., LeBlanc-Chaffin, R., Chen, H., and Kilberg, M. S. (2002) ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J. Biol. Chem. 277, 24120-24127.
248. Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., Sadri, N., Yun, C., Popko, B., Paules, R., Stojdl, D. F., Bell, J. C., Hettmann, T., Leiden, J. M., and Ron, D. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619-633.
249. Sato, H., Nomura, S., Maebara, K., Sato, K., Tamba, M., and Bannai, S. (2004) Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem. Biophys. Res. Commun. 325, 109-116.
250. Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K., and Hayashi, H. (2005) TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J. 24, 1243-1255.
251. Varfolomeev, E. E., and Ashkenazi, A. (2004) Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491-497.
252. Davis, R. J. (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
253. Yamamoto, K., Ichijo, H., and Korsmeyer, S. J. (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell Biol. 19, 8469-8478.
254. Deng, X., Xiao, L., Lang, W., Gao, F., Ruvolo, P., and May, W. S., Jr. (2001) Novel role for JNK as a stress-activated Bcl2 kinase. J. Biol. Chem. 276, 23681-23688.
255. Harris, C. A., and Johnson, E. M., Jr. (2001) BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276, 37754-37760.
256. Maundrell, K., Antonsson, B., Magnenat, E., Camps, M., Muda, M., Chabert, C., Gillieron, C., Boschert, U., Vial-Knecht, E., Martinou, J. C., and Arkinstall, S. (1997) Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272, 25238-25242.
257. Donovan, N., Becker, E. B., Konishi, Y., and Bonni, A. (2002) JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J. Biol. Chem. 277, 40944-40949.
258. Lei, K., and Davis, R. J. (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100, 2432-2437.
259. Wang, X., Martindale, J. L., Liu, Y., and Holbrook, N. J. (1998) The cellular response to oxidative stress: Influences of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 333 (Part 2), 291-300.
260. Cheng, J. Z., Singhal, S. S., Saini, M., Singhal, J., Piper, J. T., Van Kuijk, F. J., Zimniak, P., Awasthi, Y. C., and Awasthi, S. (1999) Effects of mGST A4 transfection on 4-hydroxynonenal-mediated apoptosis and differentiation of K562 human erythroleukemia cells. Arch. Biochem. Biophys. 372, 29-36.
261. Soh, Y., Jeong, K. S., Lee, I. J., Bae, M. A., Kim, Y. C., and Song, B. J. (2000) Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol. Pharmacol. 58, 535-541.
262. Yoon, S. O., Kim, M. M., Park, S. J., Kim, D., Chung, J., and Chung, A. S. (2002) Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J. 16, 111-113.
263. Aoki, H., Kang, P. M., Hampe, J., Yoshimura, K., Noma, T., Matsuzaki, M., and Izumo, S. (2002) Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J. Biol. Chem. 277, 10244-10250.
264. Parola, M., Robino, G., Marra, F., Pinzani, M., Bellomo, G., Leonarduzzi, G., Chiarugi, P., Camandola, S., Poli, G., Waeg, G., Gentilini, P., and Dianzani, M. U. (1998) HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102, 1942-1950.
265. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
266. Wu, Y., Kwon, K. S., and Rhee, S. G. (1998) Probing cellular protein targets of H2O2 with fluorescein-conjugated iodoacetamide and antibodies to fluorescein. FEBS Lett. 440, 111-115.
267. Meng, T. C., Fukada, T., and Tonks, N. K. (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol. Cell 9, 387-399.
268. Bonizzi, G., and Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
269. Yamamoto, Y., and Gaynor, R. B. (2004) IκB kinases: Key regulators of the NF-κB pathway. Trends Biochem. Sci. 29, 72-79.
270. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., and Baldwin, A. S., Jr. (1998) NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
271. Chen, C., Edelstein, L. C., and Gelinas, C. (2000) The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell Biol. 20, 2687-2695.
272. Zong, W. X., Edelstein, L. C., Chen, C., Bash, J., and Gelinas, C. (1999) The prosurvival Bcl-2 homologue Bf1-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes Dev. 13, 382-387.
273. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. (1996) TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274, 784-787.
274. De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., and Franzoso, G. (2001) Induction of gadd45/3 by NF-κB downregulates pro-apoptotic JNK signaling. Nature 414, 308-313.
275. Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., and Lin, A. (2001) Inhibition of JNK activation through NF-κB target genes. Nature 414, 313-317.
276. Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., and Santoro, M. G. (2000) Antiinflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403, 103-108.
277. Ji, C., Kozak, K. R., and Marnett, L. J. (2001) IκB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 276, 18223-18228.
278. Korn, S. H., Wouters, E. F., Vos, N., and Janssen-Heininger, Y. M. (2001) Cytokine-induced activation of nuclear factor-κ B is inhibited by hydrogen peroxide through oxidative inactivation of IκB kinase. J. Biol. Chem. 276, 35693-35700.
279. Valacchi, G., Pagnin, E., Phung, A., Nardini, M., Schock, B. C., Cross, C. E., and van der Vliet, A. (2005) Inhibition of NFκB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox Signaling 7, 25-31.
280. Horton, N. D., Biswal, S. S., Corrigan, L. L., Bratta, J., and Kehrer, J. P. (1999) Acrolein causes inhibitor κB-independent decreases in nuclear factor κB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 274, 9200-9206.
281. Page, S., Fischer, C., Baumgartner, B., Haas, M., Kreusel, U., Loidl, G., Hayn, M., Ziegler-Heitbrock, H. W., Neumeier, D., and Brand, K. (1999) 4-Hydroxynonenal prevents NF-κB activation and tumor necrosis factor expression by inhibiting IκB phosphorylation and subsequent proteolysis. J. Biol. Chem. 274, 11611-11618.
282. Stewart, Z. A., and Pietenpol, J. A. (2001) p53 Signaling and cell cycle checkpoints. Chem. Res. Toxicol. 14, 243-263.
283. Nakamura, Y. (2004) Isolation of p53-target genes and their functional analysis. Cancer Sci. 95, 7-11.
284. Chipuk, J. E., Maurer, U., Green, D. R., and Schuler, M. (2003) Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 4, 371-381.
285. Marchenko, N. D., Zaika, A., and Moll, U. M. (2000) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 275, 16202-16212.
286. Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., and Green, D. R. (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303, 1010-1014.
287. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., and Moll, U. M. (2003) p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 11, 577-590.
288. Erster, S., Mihara, M., Kim, R. H., Petrenko, O., and Moll, U. M. (2004) In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell Biol. 24, 6728-6741.
289. Leu, J. I., Dumont, P., Hafey, M., Murphy, M. E., and George, D. L. (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak-Mc11 complex. Nat. Cell Biol. 6, 443-450.
290. Martindale, J. L., and Holbrook, N. J. (2002) Cellular response to oxidative stress: Signaling for suicide and survival. J. Cell. Physiol. 192, 1-15.
291. Ji, C., Rouzer, C. A., Marnett, L. J., and Pietenpol, J. A. (1998) Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis 19, 1275-1283.
292. Haynes, R. L., Brune, B., and Townsend, A. J. (2001) Apoptosis in RAW 264.7 cells exposed to 4-hydroxy-2-nonenal: Dependence on cytochrome C release but not p53 accumulation. Free Radical Biol. Med. 30, 884-894.
293. Moos, P. J., Edes, K., and Fitzpatrick, F. A. (2000) Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc. Natl. Acad. Sci. U.S.A. 97, 9215-9220.
294. Moos, P. J., Edes, K., Cassidy, P., Massuda, E., and Fitzpatrick, F. A. (2003) Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J. Biol. Chem. 278, 745-750.
295. Shibata, T., Yamada, T., Ishii, T., Kumazawa, S., Nakamura, H., Masutani, H., Yodoi, J., and Uchida, K. (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278, 26046-26054.
296. Li, L., Hamilton, R. F., Jr., Kirichenko, A., and Holian, A. (1996) 4-Hydroxynonenal-induced cell death in murine alveolar macrophages. Toxicol. Appl. Pharmacol. 139, 135-143.
297. Ji, C., Amarnath, V., Pietenpol, J. A., and Marnett, L. J. (2001) 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem. Res. Toxicol. 14, 1090-1096.
298. Kruman, I., Bruce-Keller, A. J., Bredesen, D., Waeg, G., and Mattson, M. P. (1997) Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5089-5100.
299. Hauptlorenz, S., Esterbauer, H., Moll, W., Pumpel, R., Schauenstein, E., and Puschendorf, B. (1985) Effects of the lipid peroxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. Biochem. Pharmacol. 34, 3803-3809.
300. Kaneko, T., Kaji, K., and Matsuo, M. (1988) Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells. Chem.-Biol. Interact. 67, 295-304.
301. West, J. D., Ji, C., Duncan, S. T., Amarnath, V., Schneider, C., Rizzo, C. J., Brash, A. R., and Marnett, L. J. (2004) Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem. Res. Toxicol. 17, 453-462.
302. Lin, D., Lee, H. G., Liu, Q., Perry, G., Smith, M. A., and Sayre, L. M. (2005) 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18, 1219-1231.
303. Jian, W., Arora, J. S., Oe, T., Shuvaev, V. V., and Blair, I. A. (2005) Induction of endothelial cell apoptosis by lipid hydroperoxide-derived bifunctional electrophiles. Free Radical Biol. Med. 39, 1162-1176.
304. Cajone, F., Sauna, M., and Benelli-Zazzera, A. (1989) 4-Hydroxynonenal induces a DNA-binding protein similar to the heat-shock factor. Biochem. J. 262, 977-979.
305. Neely, M. D., Zimmerman, L., Picklo, M. J., Ou, J. J., Morales, C. R., Montine, K. S., Amaranth, V., and Montine, T. J. (2000) Congeners of N(α)-acetyl-L-cysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radical Biol. Med. 29, 1028-1036.
306. Fukuda, A., Osawa, T., Hitomi, K., and Uchida, K. (1996) 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: Protein modification and redox alteration. Arch. Biochem. Biophys. 333, 419-426.
307. Nakajima, A., Yamada, K., Zou, L. B., Yan, Y., Mizuno, M., and Nabeshima, T. (2002) Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels. Free Radical Biol. Med. 32, 1324-1332.
308. Sampey, B. P., Korourian, S., Ronis, M. J., Badger, T. M., and Petersen, D. R. (2003) Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin. Exp. Res. 27, 1015-1022.
309. Carbone, D. L., Doorn, J. A., Kiebler, Z., Ickes, B. R., and Petersen, D. R. (2005) Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 315, 8-15.
310. Carbone, D. L., Doorn, J. A., Kiebler, Z., Sampey, B. P., and Petersen, D. R. (2004) Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 17, 1459-1467.
311. Carbone, D. L., Doorn, J. A., Kiebler, Z., and Petersen, D. R. (2005) Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem. Res. Toxicol. 18, 1324-1331.
312. Pandey, P., Saleh, A., Nakazawa, A., Kumar, S., Srinivasula, S. M., Kumar, V., Weichselbaum, R., Nalin, C., Alnemri, E. S., Kufe, D., and Kharbanda, S. (2000) Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19, 4310-4322.
313. Watson, A. D., Leitinger, N., Navab, M., Faull, K. F., Horkko, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., Subbanagounder, G., Fogelman, A. M., and Berliner, J. A. (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low-density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J. Biol. Chem. 272, 13597-135607.
314. Yeh, M., Gharavi, N. M., Choi, J., Hsieh, X., Reed, E., Mouillesseaux, K. P., Cole, A. L., Reddy, S. T., and Berliner, J. A. (2004) Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J. Biol. Chem. 279, 30175-30181.
315. Davies, S. S., Pontsler, A. V., Marathe, G. K., Harrison, K. A., Murphy, R. C., Hinshaw, J. C., Prestwich, G. D., Hilaire, A. S., Prescott, S. M., Zimmerman, G. A., and McIntyre, T. M. (2001) Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 276, 16015-16023.
316. Subbanagounder, G., Deng, Y., Borromeo, C., Dooley, A. N., Berliner, J. A., and Salomon, R. G. (2002) Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vasc. Pharmacol. 38, 201-209.
317. Gugiu, B. G., and Salomon, R. G. (2003) Total syntheses of bioactive oxidized ethanolamine phospholipids. Org. Lett. 5, 2797-2799.
318. Sun, M., Deng, Y., Batyreva, E., Sha, W., and Salomon, R. G. (2002) Novel bioactive phospholipids: Practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1). J. Org. Chem. 67, 3575-3584.
319. Mittl, P. R., Di Marco, S., Krebs, J. F., Bai, X., Karanewsky, D. S., Priestle, J. P., Tomaselli, K. J., and Grutter, M. G. (1997) Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272, 6539-6547.